Trial intelligence / Profile preview

Combined IV Tranexamic Acid and Topical Floseal in THA

NCT03623789Phase 4Unknown

Sponsor
Chang Gung Memorial Hospital
Start
Aug 2018
Primary completion
Jul 2020
Modality
Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of gelatin + thrombin in osteoarthritis (OA), inflammatory arthritis, gouty arthritis and 2 more, sponsored by Chang Gung Memorial Hospital. Status: unknown.

02

Drugs

gelatin + thrombin
03

Conditions

osteoarthritis (OA)inflammatory arthritisgouty arthritisacetabular dysplasiaosteonecrosis of the femoral head (ONFH)

Beyond the preview

Go deeper on NCT03623789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03623789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call